Cary Street Partners Investment Advisory LLC Has $177,000 Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cary Street Partners Investment Advisory LLC lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 71.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,777 shares of the pharmacy operator’s stock after selling 16,640 shares during the period. Cary Street Partners Investment Advisory LLC’s holdings in Walgreens Boots Alliance were worth $177,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Dark Forest Capital Management LP lifted its holdings in Walgreens Boots Alliance by 6.5% in the 3rd quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock worth $654,000 after purchasing an additional 1,804 shares during the last quarter. Deutsche Bank AG grew its stake in Walgreens Boots Alliance by 36.2% in the 3rd quarter. Deutsche Bank AG now owns 2,170,347 shares of the pharmacy operator’s stock valued at $48,269,000 after buying an additional 576,534 shares during the last quarter. Van ECK Associates Corp lifted its position in Walgreens Boots Alliance by 28.2% during the 3rd quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator’s stock worth $2,873,000 after acquiring an additional 28,400 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Walgreens Boots Alliance by 3.4% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,444,686 shares of the pharmacy operator’s stock valued at $32,130,000 after acquiring an additional 47,071 shares during the period. Finally, Vanguard Group Inc. grew its position in shares of Walgreens Boots Alliance by 14.5% in the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after purchasing an additional 10,962,030 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Insider Buying and Selling

In other news, Director Inderpal S. Bhandari acquired 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the transaction, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Manmohan Mahajan bought 6,000 shares of the company’s stock in a transaction on Tuesday, April 2nd. The shares were bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the acquisition, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on WBA. TheStreet raised Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. Truist Financial reissued a “hold” rating and issued a $25.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. TD Cowen dropped their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Bank of America reduced their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a report on Tuesday, March 26th. Finally, Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Stock Performance

WBA stock opened at $17.34 on Thursday. The stock has a market capitalization of $14.96 billion, a PE ratio of -2.48, a price-to-earnings-growth ratio of 1.10 and a beta of 0.80. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The company has a 50 day moving average price of $19.75 and a 200 day moving average price of $21.65. Walgreens Boots Alliance, Inc. has a fifty-two week low of $17.25 and a fifty-two week high of $34.60.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. During the same quarter in the prior year, the firm posted $1.16 earnings per share. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. Analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.77%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.29%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.